CASE STUDIES
From strategy to execution—measured in results that move therapies from pipeline to patients
Start-up through Acquisition
Work was proudly recognized in acquisition press release, highlighting a 29% reduction in data collection costs. The asset achieved 63% clinical remission vs. 21% placebo, contributing to a $7.1B acquisition.
Full-time clinical operations team members hired with 100% retention
25
Streamlined CRO partnerships during Ph2
20+ Countries/80+ Sites
IBD-specific staff trained with tailored programs
92M
$50M
Saved through vendor negotiations
Company acquired by Roche
$7.1B
Pre-IPO Biotech through Ph3 Ready
Led clinical operations from the ground up, managing a $100M+ portfolio, building a high performing team, and ensuring trials not only ran faster but smarter. That foundation helped the company raise $150M and go public during a volatile market.
Built and managed in-house clinical operations team as first clinical hire
20+
Faster execution of clinical trial timelines, even during COVID
22%
Avg. 1.5 years in role
92% Team Retention
Improvement in screen failure rate
17%
5 major milestones completed on time and under budget
5